SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-17-094961
Filing Date
2017-03-24
Accepted
2017-03-24 11:43:39
Documents
5
Effectiveness Date
2017-03-24

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d367274d8k.htm DEFA14A 20443
2 EX-99.1 d367274dex991.htm EX-99.1 37659
3 GRAPHIC g367274linebig.jpg GRAPHIC 33410
4 GRAPHIC g367274new.jpg GRAPHIC 100987
5 GRAPHIC g367274thomson.jpg GRAPHIC 8085
  Complete submission text file 0001193125-17-094961.txt   255830
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 781-996-4300
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36395 | Film No.: 17711728
SIC: 2834 Pharmaceutical Preparations